You are here: Industry Insights > COVID-19

News List

INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19 prnasia
December 08, 2020
?INOVIO announced it has dosed its first subject in a Phase 2 clinical trial evaluating DNA medicine INO-4800, its COVID-19 vaccine candidate, as part of its Phase 2/3 clinical trial, called INNOVATE (INovio INO-4800 Vaccine Trial for Efficacy).
Everlywell Signs Agreement to Distribute Cellex Covid-19 Rapid Antigen Test for Organizations and Public Health Agencies prnewswire
December 08, 2020
Everlywell announced it has entered into a distribution agreement with diagnostics manufacturer Cellex, the first company to receive an FDA Emergency Use Authorization for a COVID-19 antibody test.
Contributing to ACT Accelerator could generate $466 billion for major economies, says Eurasia Group report europeanpharmaceuticalreview
December 08, 2020
The report found that the 10 major economies could see a return of more than $466 billion by 2025, 12 times the total estimated cost of supporting the WHO’s Access to COVID-19 Tools (ACT) Accelerator.
COVID-19 S-Trimer vaccine candidates show promise in early trials europeanpharmaceuticalreview
December 08, 2020
When adjuvanted with GSK’s pandemic adjuvant system, the S-Trimer vaccine candidates induced the production of neutralising antibodies in all trial participants.
PureTech launches phase II ‘long COVID’ drug trial pharmatimes
December 08, 2020
PureTech has initiated a phase II trial of its investigational drug candidate LYT-100 in long COVID characterised by respiratory complications and related sequelae.
GenNext at SIRO Clinpharm expresspharma
December 08, 2020
The COVID-19 pandemic has left its mark on the clinical research and trials sector, but disruptions have only served to temper the steel of long-timers.
Bharat Biotech seeks EUA for Covaxin expresspharma
December 08, 2020
No date has been fixed as on when the SEC will meet for assessing and evaluating the applications, as per sources.
Appili announces dosing of first patient in phase 3 Covid-19 trial pharmaceutical-business-review
December 07, 2020
Appili Therapeutics announced that first patient has been dosed in the phase 3 PRESECO (preventing severe Covid disease) clinical trial to assess oral Avigan tablets (favipiravir) to treat Covid-19.
Study finds metformin reduced COVID-19 death risks in women worldpharmanews
December 07, 2020
University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients.
Sosei Heptares' COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules americanpharmaceuticalreview
December 07, 2020
Sosei announces a progress update for its R&D program focused on the design and development of novel drugs targeting the SARS-CoV-2 coronavirus and to treat COVID-19.